177 related articles for article (PubMed ID: 8809201)
1. Characterization of type I 5 alpha-reductase activity in DU145 human prostatic adenocarcinoma cells.
Kaefer M; Audia JE; Bruchovsky N; Goode RL; Hsiao KC; Leibovitch IY; Krushinski JH; Lee C; Steidle CP; Sutkowski DM; Neubauer BL
J Steroid Biochem Mol Biol; 1996 May; 58(2):195-205. PubMed ID: 8809201
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological and molecular evidence for the expression of the two steroid 5 alpha-reductase isozymes in normal and hyperplastic human prostatic cells in culture.
Berthaut I; Mestayer C; Portois MC; Cussenot O; Mowszowicz I
Prostate; 1997 Aug; 32(3):155-63. PubMed ID: 9254894
[TBL] [Abstract][Full Text] [Related]
3. 5alpha-reductase isozymes and aromatase are differentially expressed and active in the androgen-independent human prostate cancer cell lines DU145 and PC3.
Negri-Cesi P; Colciago A; Poletti A; Motta M
Prostate; 1999 Dec; 41(4):224-32. PubMed ID: 10544295
[TBL] [Abstract][Full Text] [Related]
4. Androgen-induced prostate-specific antigen gene expression is mediated via dihydrotestosterone in LNCaP cells.
Zhu YS; Cai LQ; You X; Cordero JJ; Huang Y; Imperato-McGinley J
J Androl; 2003; 24(5):681-7. PubMed ID: 12954658
[TBL] [Abstract][Full Text] [Related]
5. Comparative study of human steroid 5alpha-reductase isoforms in prostate and female breast skin tissues: sensitivity to inhibition by finasteride and epristeride.
Ranjan M; Diffley P; Stephen G; Price D; Walton TJ; Newton RP
Life Sci; 2002 May; 71(2):115-26. PubMed ID: 12031682
[TBL] [Abstract][Full Text] [Related]
6. Human osteoblast-like cells express predominantly steroid 5alpha-reductase type 1.
Issa S; Schnabel D; Feix M; Wolf L; Schaefer HE; Russell DW; Schweikert HU
J Clin Endocrinol Metab; 2002 Dec; 87(12):5401-7. PubMed ID: 12466325
[TBL] [Abstract][Full Text] [Related]
7. 5alpha-reductase and 17beta-hydroxysteroid dehydrogenase expression in epithelial cells from hyperplastic and malignant human prostate.
Délos S; Carsol JL; Fina F; Raynaud JP; Martin PM
Int J Cancer; 1998 Mar; 75(6):840-6. PubMed ID: 9506528
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of the activity of 'basic' 5 alpha-reductase (type 1) detected in DU 145 cells and expressed in insect cells.
Délos S; Iehlé C; Martin PM; Raynaud JP
J Steroid Biochem Mol Biol; 1994 Mar; 48(4):347-52. PubMed ID: 8142312
[TBL] [Abstract][Full Text] [Related]
9. Kinetic analysis of LY320236: competitive inhibitor of type I and non-competitive inhibitor of type II human steroid 5alpha-reductase.
McNulty AM; Audia JE; Bemis KG; Goode RL; Rocco VP; Neubauer BL
J Steroid Biochem Mol Biol; 2000; 72(1-2):13-21. PubMed ID: 10731633
[TBL] [Abstract][Full Text] [Related]
10. Dihydrotestosterone and the concept of 5alpha-reductase inhibition in human benign prostatic hyperplasia.
Bartsch G; Rittmaster RS; Klocker H
Eur Urol; 2000 Apr; 37(4):367-80. PubMed ID: 10765065
[TBL] [Abstract][Full Text] [Related]
11. Differential effect of finasteride on the tissue androgen concentrations in benign prostatic hyperplasia.
Habib FK; Ross M; Tate R; Chisholm GD
Clin Endocrinol (Oxf); 1997 Feb; 46(2):137-44. PubMed ID: 9135694
[TBL] [Abstract][Full Text] [Related]
12. Effects of the anti-androgen finasteride on the modulatory actions of oestradiol on androgen metabolism by human gingival fibroblasts.
Tilakaratne A; Soory M
Arch Oral Biol; 2001 Feb; 46(2):109-15. PubMed ID: 11163318
[TBL] [Abstract][Full Text] [Related]
13. 5 alpha-reductase in intact DU145 cells: evidence for isozyme I and evaluation of novel inhibitors.
Reichert W; Jose J; Hartmann RW
Arch Pharm (Weinheim); 2000 Jul; 333(7):201-4. PubMed ID: 10965593
[TBL] [Abstract][Full Text] [Related]
14. Testosterone metabolism in primary cultures of human prostate epithelial cells and fibroblasts.
Délos S; Carsol JL; Ghazarossian E; Raynaud JP; Martin PM
J Steroid Biochem Mol Biol; 1995 Dec; 55(3-4):375-83. PubMed ID: 8541234
[TBL] [Abstract][Full Text] [Related]
15. Identification and partial characterization of two steroid 5 alpha-reductase isozymes in the canine prostate.
Span PN; Schalken JA; Sweep FG; Smals AG
Prostate; 1998 Feb; 34(3):222-30. PubMed ID: 9492851
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of 5alpha-reductase in rat prostate reveals differential regulation of androgen-response gene expression by testosterone and dihydrotestosterone.
Dadras SS; Cai X; Abasolo I; Wang Z
Gene Expr; 2001; 9(4-5):183-94. PubMed ID: 11444528
[TBL] [Abstract][Full Text] [Related]
17. Comparison of testosterone metabolism in benign prostatic hyperplasia and human prostate cancer cell lines in vitro.
Smith CM; Ballard SA; Wyllie MG; Masters JR
J Steroid Biochem Mol Biol; 1994 Aug; 50(3-4):151-9. PubMed ID: 7519439
[TBL] [Abstract][Full Text] [Related]
18. 5 alpha-reductase-catalyzed conversion of testosterone to dihydrotestosterone is increased in prostatic adenocarcinoma cells: suppression by 15-lipoxygenase metabolites of gamma-linolenic and eicosapentaenoic acids.
Pham H; Ziboh VA
J Steroid Biochem Mol Biol; 2002 Nov; 82(4-5):393-400. PubMed ID: 12589947
[TBL] [Abstract][Full Text] [Related]
19. Responses of LNCaP prostatic adenocarcinoma cell cultures to LY300502, a benzoquinolinone human type I 5alpha-reductase inhibitor.
Sutkowski DM; Audia JE; Goode RL; Hsiao KC; Leibovitch IY; McNulty AM; Neubauer BL
Prostate Suppl; 1996; 6():62-6. PubMed ID: 8630232
[TBL] [Abstract][Full Text] [Related]
20. 5alpha-reductase activity in the prostate.
Steers WD
Urology; 2001 Dec; 58(6 Suppl 1):17-24; discussion 24. PubMed ID: 11750244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]